Read the new
The discovery provides intriguing new clues as to the cause of the disease and may lead to the development of novel therapeutic strategies.
Ernest Giralt, coordinator of the IRB Barcelona Chemistry and Molecular Pharmacology Programme and head of the Design, Synthesis and Structure of Peptides and Proteins Group, is interviewed in the "Interview of the Month " section of the digital newsletter "PCB.info”, a publication of the Barcelona Science Park. In this interview, Giralt explains his research interests and personal motivations, and reveals his talent and enigmatic personality.
The scientific journalist Pere Estupinyà has written an entertaining account in his blog in the newspaper El País “Science notes from MIT” about five researchers that he met during a visit he made to IRB Barcelona in May.
Read the article (in Spanish):
The specialized journal Medicos y Medicinas echoes on the collaborative agreement between Ernest Giralt’s and Miquel Pons’ groups with biotech companies to explore advanced methods for obtaining drugs.
Diario Medico reports on the two TRACE projects that the Ministry of Science has awarded to Ernest Giralt and Miquel Pons at IRB Barcelona. The 2-year alliance with the biotech companies Intelligent Pharma and Lead Molecular Design seeks to optimize the identification of new pharmacological agents.
Scientists Ernest Giralt and Miquel Pons receive funding from the Spanish Ministry of Science and Innovation to collaborate with the biotech companies Intelligent Pharma and Lead Molecular Design.
The coordinator of the Chemistry and Molecular Pharmacology Programme at IRB Barcelona is an international authority on the synthesis and design of biomolecules.
Diario Médico reports on a study headed by Ernest Giralt at IRB Barcelona on the cellular communication capacity of the G-protein, a mediator in signal trafficking from outside to inside the cell.
Read the news